Lipocine Inc. financial statements
Lipocine Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 1.98M | 10-K |
| Net income | −USD 9.63M | 10-K |
| Cash and equivalents | USD 5.21M | 10-Q |
| Total debt | USD 449.59K | EODHD |